A sugar binding protein cyanovirin-N blocks herpes simplex virus type-1 entry and cell fusion

Antiviral Research

Volumn 84, Issue 1, 2009, Pages 67-75

  Tiwari, Vaibhav ^a,b   Shukla, Shripaad Y ^a   Shukla, Deepak ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Cyanovirin N; HSV 1; Microbicide; Viral entry

Indexed keywords

CYANOVIRIN N; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL FUSION; CONTROLLED STUDY; DRUG POTENCY; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; VIRION; VIRUS CELL INTERACTION; VIRUS ENTRY;

ANIMALS; ANTIVIRAL AGENTS; BACTERIAL PROTEINS; CARRIER PROTEINS; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; MEMBRANE FUSION; VIRUS INTERNALIZATION;

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 69249232037     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.07.014     Document Type: Article

References (53)

1. Balzarini J. Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses?. Antivir. Chem. Chemother. 18 (2007) 1-11
2. Barrientos L.G., O'Keefe B.R., Bray M., Sanchez A., Gronenborn A.M., and Boyd M.R. Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus. Antiviral Res. 58 (2003) 47-56
3. Bolmstedt A.J., O'Keefe B.R., Shenoy S.R., McMahon J.B., and Boyd M.R. Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner. Mol. Pharmacol. 59 (2001) 949-954
4. Boyd M.R., Gustafson K.R., McMahon J.B., Shoemaker R.H., O'Keefe B.R., Mori T., Gulakowski R.J., Wu L., Rivera M.I., Laurencot C.M., Currens M.J., Cardellina II J.H., Buckheit Jr. R.W., Nara P.L., Pannell L.K., Sowder II R.C., and Henderson L.E. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob. Agents Chemother. 41 (1997) 1521-1530
5. Buffa V., Stieh D., Mamhood N., Hu Q., Fletcher P., and Shattock R.J. Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models. J. Gen. Virol. 90 (2009) 234-243
6. Cocchi F., Menotti L., Mirandola P., Lopez M., and Campadelli-Fiume G. The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells. J. Virol. 72 (1998) 9992-10002
7. Campadelli-Fiume G., Cocchi F., Menotti L., and Lopez M. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev. Med. Virol. 10 (2000) 305-319
8. Clement C., Tiwari V., Scanlan P.M., Valyi-Nagy T., Yue B.Y.J.T., and Shukla D. A novel role for phagocytosis-like uptake in herpes simplex virus entry. J. Cell Biol. 174 (2006) 1009-1021
9. Cohen G.H., Long D., Matthews J.T., May M., and Eisenberg R. Glycopeptides of the type-common glycoprotein gD of herpes simplex virus types 1 and 2. J. Virol. 46 (1983) 679-689
10. Desai P., and Person S. Incorporation of the green fluorescent protein into the herpes simplex virus type 1 capsid. J. Virol. 72 (1998) 7563-7568
11. Dey B., Lerner D.L., Lusso P., Boyd M.R., Elder J.H., and Berger E.A. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses. J. Virol. 74 (2000) 4562-4569
12. Dimitrov D.S. Virus entry: molecular mechanism and biomedical applications. Nat. Rev. 2 (2004) 109-122
13. Eisenberg R.J., Long D., Ponce de Leon M., Matthews J.T., Spear P.G., Gibson M.G., Lasky L.A., Berman P., Golub E., and Cohen G.H. Localization of epitopes of gD of herpes simplex virus type 1 glycoprotein D. J. Virol. 53 (1985) 634-644
14. Ellison A.R., Yang L., Cevallos A.V., and Margolis T.P. Analysis of the herpes simplex virus type 1 UL6 gene in patients with stromal keratitis. Virology 310 (2003) 24-28
15. Helle F., Wychowski C., Vu-Dac N., Gustafson K.R., Voisset C., and Dubuisson J. Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans. J. Biol. Chem. 281 (2006) 25177-25183
16. Herold B.C., WuDunn D., Soltys N., and Spear P.G. Glycoprotein C of herpes simplex virus type 1 plays a principle role in the adsorption of virus to cells and in infectivity. J. Virol. 65 (1991) 1090-1098
17. Hill J.M., Ball M.J., Neumann D.M., Azcuy A.M., Bhattacharjee P.S., Bouhanik S., Clement C., Lukiw W.J., Foster T.P., Kumar M., Kaufman H.E., and Thompson H.W. The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender. J. Virol. 82 (2008) 8230-8234
18. Kaye S.B., Baker K., Bonshek R., Maseruka H., Grinfeld E., Tullo A., Easty D.L., and Hart C.A. Human herpesviruses in the cornea. Br. J. Opthalmol. 84 (2000) 563-571
19. Krummenacher C., Nicola A.V., Whitbeck J.C., Lou H., Hou W., Lambris J.D., Geraghty R.J., Spear P.G., Cohen G.H., and Eisenberg R.J. Herpes simplex virus glycoprotein D can bind to poliovirus receptor related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry. J. Virol. 72 (1998) 7064-7074
20. Krummenacher C., Rux A.H., Whitbeck J.C., Ponce-de-Leon M., Lou H., Baribaud I., Hou W., Zou C., Geraghty R.J., Spear P.G., Eisenberg R.J., and Cohen G.H. The first immunoglobulin-like domain of HveC is sufficient to bind herpes simplex virus gD with full affinity while the third domain is involved in oligomerization of HveC. J. Virol. 73 (1999) 8127-8137
21. Krummenacher C., Baribaud I., Ponce de Leon M., Whitbeck J.C., Lou H., Cohen G.H., and Eisenberg R.J. Localization of a binding site for herpes simplex virus glycoprotein D on herpesvirus entry mediator C by using antireceptor monoclonal antibodies. J. Virol. 74 (2000) 10863-10872
22. Kwon B.S., Tan K.B., Ni J., Oh K.O., Lee Z.H., Kim Y.J., Wang S., Gentz R., Yu G.L., Harrop J., Lyn S.D., Silverman C., Porter T.G., Truneh A., and Young P.R. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J. Biol. Chem. 272 (1997) 14272-14276
23. Liesegang T.J., Melton L.J., Daly P.J., and Ilstrup D.M. Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch. Ophthalmol. 107 (1989) 1155-1159
24. Liesegang T.J. Herpes simplex virus epidemiology and ocular importance. Cornea 20 (2001) 1-13
25. Lopez M., Cocchi F., Menotti L., Avitabile E., Dubreuil P., and Campadelli-Fiume G. Nectin2α (PRR2α or HveB) and nectin2δ are low-efficiency mediators for entry of herpes simplex virus mutants carrying the Leu25Pro substitution in glycoprotein D. J. Virol. 74 (2000) 1267-1274
26. Marsters S.A., Ayres T.M., Skubatch M., Gary C.L., Rothe M., and Ashkenazi A. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kB and AP-1. J. Biol. Chem. 272 (1997) 14029-14032
27. Martinez W.M., and Spear P.G. Amino acid substitution in the V domain of nectin-1 (HveC) that impair entry activity for herpes simplex virus type 1 and 2 but not for pseudorabies virus or bovine herpesvirus 1. J. Virol. 76 (2002) 7255-7262
28. Milne R.S., Connolly S.A., Krummenacher C., Eisenberg R.J., and Cohen G.H. Porcine, HveC, a member of the highly conserved HveC/nectin 1 family, is a functional alphaherpesvirus receptor. Virology 281 (2001) 315-328
29. Montgomery R.I., Warner M.S., Lum B.J., and Spear P.G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87 (1996) 427-436
30. Spear P.G. Entry of alphaherpesviruses into cells. Semin. Virol. 4 (1993) 167-180
31. O'Keefe B.R., Shenoy S.R., Xie D., Zhang W., Muschik J.M., Currens M.J., Chaiken I., and Boyd M.R. Analysis of the interaction between the HIV-inactivating protein cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41. Mol. Pharmacol. 58 (2000) 982-992
32. O'Keefe B.R., Smee D.F., Turpin J.A., Saucedo C.J., Gustafson K.R., Mori T., Blakeslee D., Buckheit R., and Boyd M.R. Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin. Antimicrob. Agents Chemother. 47 (2003) 2518-2525
33. Perez-Romero P., Perez A., Capul A., Montgomery R., and Fuller A.O. Herpes simplex virus entry mediator associates in infected cells in a complex with viral proteins gD and at least gH. J. Virol. 79 (2005) 4540-4544
34. Pertel P., Fridberg A., Parish M., and Spear P.G. Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate. Virology 279 (2001) 313-324
35. Richart S.M., Simpson S.A., Krummenacher C., Whitbeck J.C., Pizer L.I., Cohen G.H., Eisenberg R.J., and Wilcox C.L. Entry of herpes simplex virus type 1 into primary sensory neurons in vitro is mediated by nectin-1/HveC. J. Virol. 77 (2003) 3307-3311
36. Scanlan P.M., Tiwari V., Bommireddy S., and Shukla D. Cellular expression of gH confers resistance to herpes simplex virus type-1 entry. Virology 312 (2003) 14-24
37. Shenoy S.R., O'Keefe B.R., Bolmstedt A.J., Cartner L.K., and Boyd M.R. Selective interactions of the human immunodeficiency virus-inactivating protein cyanovirin-N with high-mannose oligosaccharides on gp120 and other glycoproteins. J. Pharmacol. Exp. Ther. 297 (2001) 704-710
38. Shieh M.T., WuDunn D., Montgomery R.I., Esko J.D., and Spear P.G. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116 (1992) 1273-1281
39. Sieczkarski S.B., and Whittaker G.R. Viral entry. Curr. Top. Microbiol. Immunol. 285 (2005) 1-23
40. Spear P.G., and Longnecker R. Herpesvirus entry: an update. J. Virol. 77 (2003) 10179-10185
41. Spear P.G., Eisenberg R.J., and Cohen G.H. Three classes of cell surface receptors for alphaherpesvirus entry. Virology 275 (2000) 1-8
42. Shukla D., Dal Canto M.C., Rowe C.L., and Spear P.G. Striking similarity of murine nectin-1α to human nectin-1α (HveC) in sequence and activity as a glycoprotein D receptor for alphaherpesvirus entry. J. Virol. 74 (2000) 11773-11781
43. Shukla D., Liu J., Blaiklock P., Shworak N.W., Bai X., Esko J.D., Cohen G.H., Eisenberg R.J., Rosenberg R.D., and Spear P.G. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99 (1999) 13-22
44. Tiwari V., Clement C., Duncan M.B., Chen J., Liu J., and Shukla D. A role for 3-O-sulfated heparin sulfate in cell fusion induced by herpes simplex virus type 1. J. Gen. Virol. 85 (2004) 805-809
45. Tiwari V., Clement C., Xu D., Valyi-Nagy T., Yue B.Y., Liu J., and Shukla D. Role for 3-O-sulfated heparan sulfate as the receptor for herpes simplex virus type 1 entry into primary human corneal fibroblasts. J. Virol. 80 (2006) 8970-8980
46. Tiwari V., Clement C., Scanlan P.M., Kowlessur D., Yue B.Y., and Shukla D. A role for herpesvirus entry mediator as the receptor for herpes simplex virus 1 entry into primary human trabecular meshwork cells. J. Virol. 79 (2005) 13173-13179
47. Tiwari V., Shukla S.Y., Yue B.Y., and Shukla D. Herpes simplex virus type 2 entry into cultured human corneal fibroblasts is mediated by herpesvirus entry mediator. J. Gen. Virol. 88 (2007) 2106-2110
48. Tiwari V., ten Dam G.B., Yue B.Y., van Kuppevelt T.H., and Shukla D. Role of 3-O-sulfated heparan sulfate in virus-induced polykaryocyte formation. FEBS Lett. 18 581 (2007) 4468-4472
49. Tiwari V., Oh M.J., Kovacs M., Shukla S.Y., Valyi-Nagy T., and Shukla D. Role for nectin-1 in herpes simplex virus 1 entry and spread in human retinal pigment epithelial cells. FEBS J. 275 (2008) 5272-5285
50. Tsai C.C., Emau P., Jiang Y., Agy M.B., Shattock R.J., Schmidt A., Morton W.R., Gustafson K.R., and Boyd M.R. Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models. AIDS Res. Hum. Retroviruses 20 (2004) 11-18
51. Warner M.S., Geraghty R.J., Martinez W.M., Montgomery R.I., Whitbeck J.C., Xu R., Eisenberg R.J., Cohen G.H., and Spear P.G. A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology 246 (1998) 179-189
52. Whitbeck J.C., Muggeridge M.I., Rux A.H., Hou W., Krummenacher C., Lou H., Geelen A.V.A.N., Eisenberg R.J., and Cohen G.H. The major neutralizing antigenic site on herpes simplex virus glycoprotein D overlaps a receptor-binding domain. J. Virol. 73 (1999) 9879-9890
53. WuDunn D., and Spear P.G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63 (1989) 52-58